Evaluation of Bactericidal Activities of LY333328, Vancomycin, Teicoplanin, Ampicillin-Sulbactam, Trovafloxacin, and RP59500 Alone or in Combination with Rifampin or Gentamicin against Different Strains of Vancomycin-Intermediate Staphylococcus aureus by Time-Kill Curve Methods-Reference-Cited by-同舟云学术

Evaluation of Bactericidal Activities of LY333328, Vancomycin, Teicoplanin, Ampicillin-Sulbactam, Trovafloxacin, and RP59500 Alone or in Combination with Rifampin or Gentamicin against Different Strains of Vancomycin-Intermediate Staphylococcus aureus by Time-Kill Curve Methods

Published:1999-03 Issue:3 Volume:43 Page:717-721
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Hershberger Ellie¹²,Aeschlimann Jeffrey R.¹²,Moldovan Tabitha¹,Rybak Michael J.¹²³

Affiliation:

1. Anti-Infective Research Laboratory, Department of Pharmacy Services, Detroit Receiving Hospital and University Health Center,1

2. College of Pharmacy and Allied Health Professions,2 and

3. Department of Internal Medicine, Division of Infectious Diseases, School of Medicine,3 Wayne State University, Detroit, Michigan

Abstract

ABSTRACT This in vitro study evaluated the activities of vancomycin, LY333328, and teicoplanin alone and in combination with gentamicin, rifampin, and RP59500 against Staphylococcus aureus isolates with intermediate susceptibilities to vancomycin. Ampicillin-sulbactam and trovafloxacin were also evaluated. LY333328 and ampicillin-sulbactam resulted in bactericidal activity against all isolates. The combination of gentamicin with glycopeptides showed synergistic activity, while rifampin had no added benefit.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.43.3.717

Reference9 articles.

1. Boyce J. M. Medeiros A. A. Hiramatsu K. Clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) from the United States with subpopulations of cells with reduced susceptibility to vancomycin abstr. LB-15. Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. 1997 American Society for Microbiology Washington D.C

2. Reduced susceptibility of Staphylococcus aureus to vancomycin—Japan, 1996.;Centers for Disease Control and Prevention;Morbid. Mortal. Weekly Rep.,1997

3. Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus

4. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.;Hiramatsu K.;J. Antimicrob. Chemother.,1997

5. Vancomycin-gentamicin synergism revisited: effect of gentamicin susceptibility of methicillin-resistant Staphylococcus aureus

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Perspectives on Antimicrobial Agents: Long-Acting Lipoglycopeptides;Antimicrobial Agents and Chemotherapy;2022-06-21

2. Antimicrobial activity of essential oils against multidrug-resistant clinical isolates of the Burkholderia cepacia complex;PLOS ONE;2018-08-02

3. Probing the Mechanism of LAL-32, a Gold Nanoparticle-Based Antibiotic Discovered through Small Molecule Variable Ligand Display;Bioconjugate Chemistry;2017-06-27

4. Oritavancin Diphosphate;Hospital Pharmacy;2014-11-01

5. Release of Gentamicin and Vancomycin from Preformed Spacers in Infected Total Hip Arthroplasties: Measurement of Concentrations and Inhibitory Activity in Patients’ Drainage Fluids and Serum;The Scientific World Journal;2013